These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9130607)

  • 1. The first component of the human complement system recognizes the active fraction of heparin.
    Calabrese GC; Recondo MM; Fernández de Recondo ME; Recondo EF
    Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):237-42. PubMed ID: 9130607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active fraction of unfractionated heparin from a natural source is recognized by the first component of the complement system.
    Calabrese GC; Leocatanieto F; Recondo EF; Fernandez de Recondo ME
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL119-23. PubMed ID: 11936856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
    Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin and first complement protein recognize the same active heparin fraction.
    Calabrese GC; Recondo EF; Fernandez de Recondo ME
    Thromb Res; 2002 Mar; 105(6):537-41. PubMed ID: 12091056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.
    Abzalimov RR; Dubin PL; Kaltashov IA
    Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
    Byun Y; Jacobs HA; Kim SW
    Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M; Luppi E; Maccari F; Volpi N
    Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific electrostatic binding characteristics of the heparin-antithrombin interaction.
    Seyrek E; Dubin PL; Henriksen J
    Biopolymers; 2007 Jun; 86(3):249-59. PubMed ID: 17385667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
    Mousa SA; Fareed J
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1077-80. PubMed ID: 11892916
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns.
    Sissi C; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2003 Dec; 29(6):661-70. PubMed ID: 14719183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of antithrombin III on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro].
    Psuja P
    Acta Haematol Pol; 1988; 19(3-4):143-9. PubMed ID: 2855291
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of omega-aminoacids on the activation of the first component of complement at low ionic strength.
    Takada Y; Takada A
    Thromb Haemost; 1981 Feb; 45(1):86-9. PubMed ID: 6787729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins.
    Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2002 Aug; 28(4):355-60. PubMed ID: 12244482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding of heparin by necrotic tumour cells neutralises anticoagulant activity--implications for cancer related thromboembolism and heparin therapy.
    Morita S; Gebska MA; Kakkar AK; Scully MF
    Thromb Haemost; 2001 Aug; 86(2):616-22. PubMed ID: 11522012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of concanavalin A with a fraction of dermatan sulfate containing a very high anticoagulant activity.
    Fernández de Recondo ME; Monge JC; Recondo EF
    Cell Mol Biol (Noisy-le-grand); 1995 Jun; 41(4):465-72. PubMed ID: 7549783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.